307 related articles for article (PubMed ID: 27193073)
41. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
42. Correlation between alpha activity and neuropsychometric tests in Parkinson's disease.
Yılmaz NH; Çalışoğlu P; Güntekin B; Hanoğlu L
Neurosci Lett; 2020 Nov; 738():135346. PubMed ID: 32911456
[TBL] [Abstract][Full Text] [Related]
43. Memory deficits in advanced Parkinson's disease.
Fischer P; Gatterer G; Simanyi M; Jellinger K; Marterer A; Danielczyk K; Danielczyk W
J Neural Transm Park Dis Dement Sect; 1990; 2(1):59-70. PubMed ID: 2357271
[TBL] [Abstract][Full Text] [Related]
44. Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD.
Stuart S; Lawson RA; Yarnall AJ; Nell J; Alcock L; Duncan GW; Khoo TK; Barker RA; Rochester L; Burn DJ;
Mov Disord; 2019 Nov; 34(11):1690-1698. PubMed ID: 31442355
[TBL] [Abstract][Full Text] [Related]
45. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
Hobson P; Meara J
Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
[TBL] [Abstract][Full Text] [Related]
46. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia.
Kim JS; Youn J; Suh MK; Kim TE; Chin J; Park S; Cho JW
Can J Neurol Sci; 2015 Nov; 42(6):395-400. PubMed ID: 26551089
[TBL] [Abstract][Full Text] [Related]
47. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.
Ceccarini J; Casteels C; Ahmad R; Crabbé M; Van de Vliet L; Vanhaute H; Vandenbulcke M; Vandenberghe W; Van Laere K
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2348-2357. PubMed ID: 31342135
[TBL] [Abstract][Full Text] [Related]
48. Mild cognitive impairment as a risk factor for Parkinson's disease dementia.
Hoogland J; Boel JA; de Bie RMA; Geskus RB; Schmand BA; Dalrymple-Alford JC; Marras C; Adler CH; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
Mov Disord; 2017 Jul; 32(7):1056-1065. PubMed ID: 28605056
[TBL] [Abstract][Full Text] [Related]
49. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.
Cooper JA; Sagar HJ; Jordan N; Harvey NS; Sullivan EV
Brain; 1991 Oct; 114 ( Pt 5)():2095-122. PubMed ID: 1933236
[TBL] [Abstract][Full Text] [Related]
50. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
[TBL] [Abstract][Full Text] [Related]
51. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
[TBL] [Abstract][Full Text] [Related]
52. Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
Shin JH; Shin SA; Lee JY; Nam H; Lim JS; Kim YK
Neurosci Lett; 2017 Jul; 653():250-257. PubMed ID: 28579482
[TBL] [Abstract][Full Text] [Related]
53. Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease.
Gjerde KV; Müller B; Skeie GO; Assmus J; Alves G; Tysnes OB
Acta Neurol Scand; 2018 Dec; 138(6):508-514. PubMed ID: 30058142
[TBL] [Abstract][Full Text] [Related]
54. Association of arterial stiffness with cognition in patients with Lewy body disorder.
Ryu DW; Kim JS; Lee JE; Park JW; Oh YS; An JY; Lee KS
Neurol Sci; 2017 Jul; 38(7):1307-1313. PubMed ID: 28474150
[TBL] [Abstract][Full Text] [Related]
55. Impaired frontal lobe functions in patients with Parkinson's disease and psychosis.
Thota N; Lenka A; George L; Hegde S; Arumugham SS; Prasad S; Stezin A; Kamble N; Yadav R; Pal PK
Asian J Psychiatr; 2017 Dec; 30():192-195. PubMed ID: 29101795
[TBL] [Abstract][Full Text] [Related]
56. Abnormalities in auditory and visual cognitive processes are differentiated with theta responses in patients with Parkinson's disease with and without dementia.
Güntekin B; Aktürk T; Yıldırım E; Yılmaz NH; Hanoğlu L; Yener G
Int J Psychophysiol; 2020 Jul; 153():65-79. PubMed ID: 32339563
[TBL] [Abstract][Full Text] [Related]
57. Homocysteine and cognitive function in Parkinson's disease.
Licking N; Murchison C; Cholerton B; Zabetian CP; Hu SC; Montine TJ; Peterson-Hiller AL; Chung KA; Edwards K; Leverenz JB; Quinn JF
Parkinsonism Relat Disord; 2017 Nov; 44():1-5. PubMed ID: 28807493
[TBL] [Abstract][Full Text] [Related]
58. "Pure apathy" and cognitive dysfunctions in Parkinson's disease: A meta-analytic study.
D'Iorio A; Maggi G; Vitale C; Trojano L; Santangelo G
Neurosci Biobehav Rev; 2018 Nov; 94():1-10. PubMed ID: 30114389
[TBL] [Abstract][Full Text] [Related]
59. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.
York MK; Dulay M; Macias A; Levin HS; Grossman R; Simpson R; Jankovic J
J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):789-95. PubMed ID: 17965146
[TBL] [Abstract][Full Text] [Related]
60. Prose memory in patients with idiopathic Parkinson's disease.
Lee TM; Chan CC; Ho SL; Li LS
Parkinsonism Relat Disord; 2005 Nov; 11(7):453-8. PubMed ID: 16157503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
